Learmont J C, Geczy A F, Mills J, Ashton L J, Raynes-Greenow C H, Garsia R J, Dyer W B, McIntyre L, Oelrichs R B, Rhodes D I, Deacon N J, Sullivan J S
Australian Red Cross Blood Service-New South Wales, Sydney.
N Engl J Med. 1999 Jun 3;340(22):1715-22. doi: 10.1056/NEJM199906033402203.
The Sydney Blood Bank Cohort consists of a blood donor and eight transfusion recipients who were infected before 1985 with a strain of human immunodeficiency virus type 1 (HIV-1) with a deletion in the region in which the nef gene and the long terminal repeat overlap. Two recipients have died since 1994, at 77 and 83 years of age, of causes unrelated to HIV infection; one other recipient, who had systemic lupus erythematosus, died in 1987 at 22 years of age of causes possibly related to HIV. We present longitudinal immunologic and virologic data on the six surviving members and one deceased member of this cohort through September 30, 1998.
The five surviving recipients remain asymptomatic 14 to 18 years after HIV-1 infection without any antiretroviral therapy; however, the donor commenced therapy in February 1999. In three recipients plasma concentrations of HIV-1 RNA are undetectable (<200 copies per milliliter), and in two of these three the CD4 lymphocyte counts have declined by 9 and 30 cells per cubic millimeter per year (P=0.3 and P=0.5, respectively). The donor and two other recipients have median plasma concentrations of HIV-1 RNA of 645 to 2850 copies per milliliter; the concentration has increased in the donor (P<0.001). The CD4 lymphocyte counts in these three cohort members have declined by 16 to 73 cells per cubic millimeter per year (P<0.001). In the recipient who died after 12 years of infection, the median plasma concentration of HIV-1 RNA was 1400 copies per milliliter, with a decline in CD4 lymphocyte counts of 17 cells per cubic millimeter per year (P=0.2).
After prolonged infection with this attenuated strain of HIV-1, there is evidence of immunologic damage in three of the four subjects with detectable plasma HIV-1 RNA. The CD4 lymphocyte counts appear to be stable in the three subjects in whom plasma HIV-1 RNA remains undetectable.
悉尼血库队列由一名献血者和八名输血接受者组成,他们在1985年前感染了一株1型人类免疫缺陷病毒(HIV-1),该病毒在nef基因与长末端重复序列重叠区域存在缺失。自1994年以来,两名接受者分别于77岁和83岁时死于与HIV感染无关的原因;另一名患有系统性红斑狼疮的接受者于1987年22岁时死亡,死因可能与HIV有关。我们展示了截至1998年9月30日该队列中六名存活成员和一名已故成员的纵向免疫学和病毒学数据。
五名存活的接受者在未接受任何抗逆转录病毒治疗的情况下,感染HIV-1后14至18年仍无症状;然而,献血者于1999年2月开始接受治疗。在三名接受者中,血浆HIV-1 RNA浓度检测不到(<200拷贝/毫升),在这三名接受者中的两名中,CD4淋巴细胞计数每年分别下降9个和30个/立方毫米(P分别为0.3和0.5)。献血者和另外两名接受者的血浆HIV-1 RNA中位数浓度为645至2850拷贝/毫升;献血者的浓度有所上升(P<0.001)。这三名队列成员的CD4淋巴细胞计数每年下降16至73个/立方毫米(P<0.001)。在感染12年后死亡的接受者中,血浆HIV-1 RNA中位数浓度为1400拷贝/毫升,CD4淋巴细胞计数每年下降17个/立方毫米(P=0.2)。
在长期感染这种减毒的HIV-1毒株后,在血浆HIV-1 RNA可检测到的四名受试者中的三名有免疫损伤的证据。在血浆HIV-1 RNA仍检测不到的三名受试者中,CD4淋巴细胞计数似乎稳定。